한글목차

알파선방출체 시장의 규모는 최근, 비약적으로 확대하고 있습니다. 2025년 16억 1,000만 달러에서 2026년에는 19억 9,000만 달러로, CAGR 23.6%로 성장이 전망되고 있습니다. 지금까지의 성장은 알파선 방출 방사성 핵종공급 제한, 우라늄, 라듐 등 천연자원에 대한 의존도, 표적 암 치료에 대한 인식 증가, 초기 임상시험의 출현, 생산 인프라 부족 등이 요인으로 꼽힙니다.

알파선방출체 시장 규모는 향후 수년간 급격한 성장이 전망됩니다. 2030년에는 46억 달러에 달하며, CAGR은 23.3%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 인공 방사성 핵종 생산 시설의 개발, 종양 치료에 대한 투자 증가, 뼈 전이 및 전립선암 치료에서의 채택 확대, 표적 알파 치료 기술의 발전, 의료 연구 용도 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 알파선 방출체를 이용한 암 치료법 채택 확대, 방사성 핵종 생산 및 분리 관련 연구 증가, 인공적으로 제조된 알파선 방출체의 성장, 종양학 이외의 치료 응용 분야로의 확대, 방사성 물질 취급의 안전성 및 규제 준수에 대한 관심 증가 등을 들 수 있습니다. 등을 들 수 있습니다.

암 발병률 증가는 향후 수년간 알파선 방출체 시장의 성장을 촉진할 것으로 예측됩니다. 암은 체내에서 비정상적인 세포가 통제할 수 없을 정도로 증식, 확산되어 종양을 형성하고 주변 조직으로 침범하는 질환입니다. 암 발병률 증가에는 고령화, 환경 노출, 생활습관 변화, 검출 방법의 발전 등의 요인이 영향을 미치고 있습니다. 알파선 방출체는 암 치료에서 종양세포를 정밀하게 표적화하여 파괴하는 동시에 주변 정상조직의 손상을 최소화하기 위해 사용됩니다. 예를 들어 2024년 2월 스위스에 본부를 둔 국제기구인 세계보건기구(WHO)는 2050년까지 전 세계에서 3,500만 건 이상의 신규 암이 발생할 것으로 예측했습니다. 이는 2022년에 기록된 약 2,000만 건에 비해 77% 증가한 수치입니다. 따라서 암 발병률 증가가 알파선 방출체 시장의 성장을 주도하고 있습니다.

알파선 방출체 시장에서 사업을 영위하는 기업은 경쟁 우위를 강화하기 위해 사이클로트론을 이용하여 생성되는 알파선 방출 방사성 핵종과 같은 혁신적인 솔루션에 투자하고 있습니다. 사이클로트론에서 생성되는 알파선 방출 방사성 핵종은 사이클로트론 내에서 하전 입자를 고에너지로 가속하여 생성되는 방사성동위원소로, 붕괴시 알파 입자를 방출하는 방사성동위원소입니다. 예를 들어 2023년 4월 미국 사이클로트론 및 기술 기업 Ionetix는 미시간주 랜싱에 신설된 알파 동위원소 생산 시설에서 최초의 알파선 방출 방사성 핵종인 아스타틴 211(At-211)을 생산하는데 성공했습니다. 이 시설은 사이클로트론 기술을 이용한 알파선 방출 방사성 핵종 생산에 특화된 미국 최초의 시설로 주목받고 있습니다. 생산은 알파 입자를 가속하여 높은 수율로 아스타틴 211(At-211)과 액티늄 225(Ac-225)를 생성하도록 설계된 30MeV 사이클로트론의 시운전을 통해 이루어졌습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

An alpha emitter is a form of radioactive material that releases alpha particles during radioactive decay. It includes elements such as uranium, radium, and plutonium, which undergo alpha decay as part of natural radioactive processes. Alpha emitters are important in medical treatments, particularly cancer therapy, and have applications in technologies like smoke detectors and space exploration.

The main radionuclides of alpha emitters include radium, actinium, lead, bismuth, and others. Radium is a radioactive substance used in both therapeutic and diagnostic medical procedures. The sources include natural origins, artificially produced sources, and others, while the applications include pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. They are used across various end-users such as hospitals, medical research organizations, and others.

Tariffs have influenced the alpha emitter market by increasing costs for imported radionuclides and production equipment, particularly affecting segments like radium-223, actinium-225, and bismuth-213. Asia-Pacific regions, including China and India, are highly impacted due to import dependencies. While tariffs raise production costs and may slow supply chains, they also incentivize local production, research investment, and development of alternative radionuclide sources, supporting long-term market growth.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.61 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to limited availability of alpha-emitting radionuclides, reliance on natural sources like uranium and radium, growing awareness of targeted cancer therapies, emergence of early clinical trials, limited production infrastructure.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to development of artificial radionuclide production facilities, rising investment in oncology treatments, increasing adoption in bone metastasis and prostate cancer therapies, advancement in targeted alpha therapy technologies, expanding medical research applications. Major trends in the forecast period include rising adoption of alpha-emitter-based cancer therapies, increased research in radionuclide production and isolation, growth in artificially produced alpha emitters, expansion of therapeutic applications beyond oncology, enhanced focus on safety and regulatory compliance for handling radioactive materials.

The growing prevalence of cancer is expected to drive the growth of the alpha emitter market in the coming years. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells within the body, which can form tumors and invade surrounding tissues. The increasing prevalence of cancer is influenced by factors such as aging populations, environmental exposure, lifestyle changes, and advancements in detection methods. Alpha emitters are used in cancer therapy to precisely target and destroy tumor cells while minimizing damage to nearby healthy tissues. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there will be more than 35 million new cancer cases worldwide, representing a 77% increase compared with the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the alpha emitter market.

Companies operating in the alpha-emitter market are investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to strengthen their competitive positioning. Alpha-emitting radionuclides generated using cyclotrons are radioactive isotopes that emit alpha particles during decay, produced by accelerating charged particles to high energies within a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable for being the first in the US dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. Production was achieved through the commissioning of a 30 MeV cyclotron designed to accelerate alpha particles for high-yield generation of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. With this acquisition, Bristol-Myers Squibb Co. enhances its oncology portfolio by adding innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio Inc. is a US-based provider of alpha-emitter technologies.

Major companies operating in the alpha emitter market are Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics, Oncoinvent ASA, Theragnostics Ltd., ARICEUM Therapeutics, Sirius Medical Systems B.V.

North America was the largest region in the alpha emitter market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
• 2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
• 3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
• 4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
• Subsegments:
• 1) By Radium: Radium-223; Radium-226; Radium-228
• 2) By Actinium: Actinium-227; Actinium-225
• 3) By Lead: Lead-210; Lead-212
• 4) By Bismuth: Bismuth-213; Bismuth-212
• 5) By Other Types of Radionuclides: Thorium; Polonium; Francium
• Companies Mentioned: Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH; Telix Pharmaceuticals Limited; NorthStar Medical Radioisotopes LLC; ITM Isotope Technologies Munich SE; International Isotopes Inc.; IBA Radiopharma Solutions; Orano Med LLC; Actinium Pharmaceuticals Inc.; Clarity Pharmaceuticals Ltd.; RadioMedix Inc.; Nordic Nanovector ASA; TAE Life Sciences; Fusion Pharmaceuticals Inc.; Alpha Tau Medical Ltd.; Alpha-9 Oncology; Aktis Oncology; Abdera Therapeutics; Oncoinvent ASA; Theragnostics Ltd.; ARICEUM Therapeutics; Sirius Medical Systems B.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Alpha Emitter Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Alpha Emitter Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Alpha Emitter Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Alpha Emitter Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Alpha-Emitter-Based Cancer Therapies
  • 4.2.2 Increased Research In Radionuclide Production And Isolation
  • 4.2.3 Growth In Artificially Produced Alpha Emitters
  • 4.2.4 Expansion Of Therapeutic Applications Beyond Oncology
  • 4.2.5 Enhanced Focus On Safety And Regulatory Compliance For Handling Radioactive Materials

5. Alpha Emitter Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Medical Research Institutions
• 5.3 Oncology Clinics
• 5.4 Pharmaceutical Companies
• 5.5 Nuclear Medicine Laboratories

6. Alpha Emitter Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Alpha Emitter Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Alpha Emitter PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Alpha Emitter Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Alpha Emitter Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Alpha Emitter Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Alpha Emitter Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Alpha Emitter Market Segmentation

• 9.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Radium, Actinium, Lead, Bismuth, Other Types Of Radionuclides
• 9.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Natural Sources, Artificially Produced Sources, Other Sources
• 9.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Lymphoma, Melanoma, Bone Metastasis, Other Applications
• 9.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Medical Research Institutions, Other End-Users
• 9.5. Global Alpha Emitter Market, Sub-Segmentation Of Radium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Radium-223, Radium-226, Radium-228
• 9.6. Global Alpha Emitter Market, Sub-Segmentation Of Actinium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Actinium-227, Actinium-225
• 9.7. Global Alpha Emitter Market, Sub-Segmentation Of Lead, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lead-210, Lead-212
• 9.8. Global Alpha Emitter Market, Sub-Segmentation Of Bismuth, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bismuth-213, Bismuth-212
• 9.9. Global Alpha Emitter Market, Sub-Segmentation Of Other Types Of Radionuclides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Thorium, Polonium, Francium

10. Alpha Emitter Market Regional And Country Analysis

• 10.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Alpha Emitter Market

• 11.1. Asia-Pacific Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Alpha Emitter Market

• 12.1. China Alpha Emitter Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Alpha Emitter Market

• 13.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Alpha Emitter Market

• 14.1. Japan Alpha Emitter Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Alpha Emitter Market

• 15.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Alpha Emitter Market

• 16.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Alpha Emitter Market

• 17.1. South Korea Alpha Emitter Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Alpha Emitter Market

• 18.1. Taiwan Alpha Emitter Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Alpha Emitter Market

• 19.1. South East Asia Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Alpha Emitter Market

• 20.1. Western Europe Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Alpha Emitter Market

• 21.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Alpha Emitter Market

• 22.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Alpha Emitter Market

• 23.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Alpha Emitter Market

• 24.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Alpha Emitter Market

• 25.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Alpha Emitter Market

• 26.1. Eastern Europe Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Alpha Emitter Market

• 27.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Alpha Emitter Market

• 28.1. North America Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Alpha Emitter Market

• 29.1. USA Alpha Emitter Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Alpha Emitter Market

• 30.1. Canada Alpha Emitter Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Alpha Emitter Market

• 31.1. South America Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Alpha Emitter Market

• 32.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Alpha Emitter Market

• 33.1. Middle East Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Alpha Emitter Market

• 34.1. Africa Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Alpha Emitter Market Regulatory and Investment Landscape

36. Alpha Emitter Market Competitive Landscape And Company Profiles

• 36.1. Alpha Emitter Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Alpha Emitter Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Alpha Emitter Market Company Profiles
  • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Telix Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

37. Alpha Emitter Market Other Major And Innovative Companies

• NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics

38. Global Alpha Emitter Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Alpha Emitter Market

40. Alpha Emitter Market High Potential Countries, Segments and Strategies

• 40.1 Alpha Emitter Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Alpha Emitter Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Alpha Emitter Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer